Key facts
- This page summarizes Anup Marda's Form 4 filing for Cabaletta Bio, Inc. (CABA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Mar 2026, 19:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
25% of the shares underlying this option shall vest and become exercisable on March 1, 2027, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.